CORALVILLE, IA / ACCESSWIRE / September 29, 2022 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a radiopharmaceutical company developing precision lead-212-based α-particle ...
RICHLAND, Wash. & CORALVILLE, Iowa--(BUSINESS WIRE)--Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, and Viewpoint Molecular Targeting, Inc., a ...
View, Inc. (VIEW) has been beaten down lately with too much selling pressure. While the stock has lost 25.1% over the past four weeks, there is light at the end of the tunnel as it is now in oversold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results